Abstract:Background Osteoporosis and sarcopenia are common age-related conditions characterized by the progressive loss of bone density and muscle mass, respectively. Their co-occurrence, often referred to as osteosarcopenia, presents significant challenges in elderly care due to increased fragility and functional impairment. Existing studies have identified shared pathological mechanisms between these conditions, including inflammation, hormonal imbalances, and metabolic dysregulation, but a comprehensive understanding of their molecular interplay remains incomplete. Objective This study aims to deepen our understanding of the molecular interactions between sarcopenia and osteoporosis through an integrated omics approach, revealing potential therapeutic targets and biomarkers. Methods Employing a combination of proteomics and transcriptomics analyses, this study analyzed bone and muscle tissue samples from patients diagnosed with osteoporosis and osteosarcopenia. Techniques included high-throughput sequencing and label-free proteomics, supported by advanced bioinformatics tools for data analysis and functional annotation of genes and proteins. Results The study found marked differences in gene and protein expressions between osteoporosis and osteosarcopenia tissues. Specifically, genes like PDIA5, TUBB1, and CYFIP2 in bone, along with MYH7 and NCAM1 in muscle, exhibited differential expression at both mRNA and protein levels. Pathway analyses revealed the significance of oxidative-reduction balance, cellular metabolism, and immune response in the progression of these conditions. Importantly, the study pinpointed osteoclast differentiation and NF-kappa B signaling pathways as critical in the molecular dynamics of osteosarcopenia, suggesting potential targets for therapy. Conclusions This study utilized transcriptomics and proteomics to identify key genes and proteins impacting sarcopenia and osteoporosis, employing advanced network tools to delineate interaction networks and crucial signaling pathways. It highlighted genes like PDIA5 and TUBB1, consistently expressed in both analyses, involved in pathways such as osteoclast differentiation and cytokine interactions. These insights enhance understanding of the molecular interplay in bone and muscle degeneration with aging, suggesting directions for future research into therapeutic interventions and prevention strategies for age-related degenerative diseases.

Multiomics mapping and characterization of cellular senescence in aging human skeletal muscle uncovers a novel senotherapeutic for sarcopenia

Multimodal cell atlas of the ageing human skeletal muscle

Single nuclei profiling identifies cell specific markers of skeletal muscle aging, sarcopenia and senescence

Integrated Multi-Omics Analysis Identifies Disrupted Branched-Chain Amino Acid Catabolism As Causal for Sarcopenia

Characterization of cellular senescence in aging skeletal muscle

Characterizing the skeletal muscle immune microenvironment for sarcopenia: insights from transcriptome analysis and histological validation

Characterizing the skeletal muscle immune microenvironment for sarcopenia using transcriptome analysis and histological validation

Multi-omics Research in Sarcopenia: Current Progress and Future Prospects

The Neuromuscular Junction is a Focal Point of Mtorc1 Signaling in Sarcopenia

Novel drug targets and molecular mechanisms for sarcopenia based on systems biology

Uncovering the Prominent Role of Satellite Cells in Paravertebral Muscle Development and Aging by Single-Nucleus RNA Sequencing

Dissecting Murine Muscle Stem Cell Aging through Regeneration Using Integrative Genomic Analysis

Recent advances in cell-based and cell-free therapeutic approaches for sarcopenia

Single-nucleus profiling unveils a geroprotective role of the FOXO3 in primate skeletal muscle aging

Reduced energy metabolism contributing to aging of skeletal muscle by serum metabolomics and gut microbiota analysis

Cross-Species Studies Reveal That Dysregulated Mitochondrial Gene Expression and Electron Transport Complex I Activity Are Crucial for Sarcopenia

Author Correction: Senescence Atlas Reveals an Aged-Like Inflamed Niche That Blunts Muscle Regeneration

Integrating Transcriptomic and Proteomic Data for a Comprehensive Molecular Perspective on the Association between Sarcopenia and Osteoporosis

Integrated multi-omics approach revealed cellular senescence landscape

Human skeletal muscle aging atlas

Identification of key genes and signaling pathways based on transcriptomic studies of aerobic and resistance training interventions in sarcopenia in SAMP8 mice